Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emre Cörek
Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines Under Normoxic and Hypoxic Conditions
Breast Cancer: Basic and Clinical Research
Cancer Research
Oncology
Related publications
The Dual PI3K/mTOR Inhibitor, NVP-BEZ235, Is Efficacious Against Follicular Lymphoma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Efficacy of the Dual PI3K and mTOR Inhibitor NVP-BEZ235 in Combination With Imatinib Mesylate Against Chronic Myelogenous Leukemia Cell Lines
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Specific Apoptosis Induction by the Dual PI3K/mTor Inhibitor NVP-BEZ235 in HER2 Amplified and PIK3CA Mutant Breast Cancer Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Enhances Nab-Paclitaxel Antitumor Response in Experimental Gastric Cancer
International Journal of Oncology
Cancer Research
Oncology
NVP-BEZ235, a Novel Dual PI3K/mTOR Inhibitor, Enhances the Radiosensitivity of Human Glioma Stem Cells in Vitro
Acta Pharmacologica Sinica
Medicine
Pharmacology
Preclinical Evaluation of a Novel Triple-Acting PIM/PI3K/mTOR Inhibitor, IBL-302, in Breast Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
BEZ235 Impairs Gastric Cancer Growth by Inhibition of PI3K/mTOR in Vitro and in Vivo
BMC Pharmacology
Primary Culture of Mouse Adipose and Fibrous Synovial Fibroblasts Under Normoxic and Hypoxic Conditions
Biomedical Research
Biochemistry
Medicine
Genetics
Molecular Biology
Cell Killing Efficacy of Combined Electroporation and Drug Delivery of NVP-BEZ235
Journal of Vascular and Interventional Radiology
Nuclear Medicine
Radiology
Cardiology
Cardiovascular Medicine
Imaging
Medicine